Related Experiment Video
Updated: Aug 10, 2026
Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
Overview of the use of CoQ10 in cardiovascular disease
Insights
Coenzyme Q10 (CoQ10) supplementation shows promise in managing cardiovascular diseases, potentially preventing heart conditions by inhibiting LDL oxidation and improving cellular function. Higher CoQ10 levels correlate with faster clinical improvement.
Area of Science:
- Cardiology
- Biochemistry
- Nutritional Science
Background:
- Coenzyme Q10 (CoQ10) plays a crucial role in cellular energy production and antioxidant defense.
- Statins (HMG-CoA reductase inhibitors) can lower CoQ10 levels, raising concerns about cardiovascular health.
- Cardiovascular diseases encompass a range of conditions including heart failure, ischemic heart disease, and hypertension.
Purpose of the Study:
- To review the clinical evidence for CoQ10's efficacy in various cardiovascular conditions.
- To explore CoQ10's potential role in preventing cardiovascular disease.
- To assess the impact of CoQ10 dosage on clinical outcomes.
Main Methods:
- Review of 34 controlled trials on CoQ10 in cardiovascular diseases.
- Inclusion of several open-label and long-term studies.
- Analysis of clinical effects and patient outcomes.
Main Results:
- CoQ10 has demonstrated clinical benefits in conditions like congestive heart failure and ischemic heart disease.
- Supplemental CoQ10 may prevent cardiovascular disease by inhibiting LDL oxidation and supporting mitochondrial function.
- Higher CoQ10 blood levels (> 3.5 µg/ml), achieved with higher doses, correlate with enhanced magnitude and speed of clinical improvement.
Conclusions:
- CoQ10 supplementation is a viable strategy for managing and potentially preventing cardiovascular diseases.
- Maintaining optimal CoQ10 levels is important, especially for patients on statin therapy.
- Higher doses of CoQ10 may offer superior clinical benefits in cardiovascular patients.
Abstract:
The clinical experience in cardiology with CoQ10 includes studies on congestive heart failure, ischemic heart disease, hypertensive heart disease, diastolic dysfunction of the left ventricle, and reperfusion injury as it relates to coronary artery bypass graft surgery. The CoQ10-lowering effect of HMG-CoA reductase inhibitors and the potential adverse consequences are of growing concern. Supplemental CoQ10 alters the natural history of cardiovascular illnesses and has the potential for prevention of cardiovascular disease through the inhibition of LDL cholesterol oxidation and by the maintenance of optimal cellular and mitochondrial function throughout the ravages of time and internal and external stresses. The attainment of higher blood levels of CoQ10 (> 3.5 micrograms/ml) with the use of higher doses of CoQ10 appears to enhance both the magnitude and rate of clinical improvement. In this communication, 34 controlled trials and several open-label and long-term studies on the clinical effects of CoQ10 in cardiovascular diseases are reviewed.
More Related Videos
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:26Coronary Artery Disease IV: Preventive Measures
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations